
In
November 2010, a Darvon and Darvocet recall was
announced after the FDA concluded that side effects of propoxyphene can cause
significant changes to the electrical activity of the heart. The heart
problems may increase the risk of heart arrhythmias, myocardial infarction
and sudden death. All of the Dravon and Darvocet lawsuits allege that the
drug makers failed to adequately warn consumers or the medical community about
the risk of serious and potentially fatal heart rhythm problems. Propoxyphene bans were announced in the United Kingdom
almost six years ago, and in Europe, almost 1½ years ago. According to Public
Citizen, the FDA’s delay has cost thousands of lives.
The U.S. Judicial Panel on Multidistrict Litigation issued an
order establishing the Darvocet MDL on August 16, which will result in the
transfer of at least 17 cases that have been filed so far. In addition, as Darvon and Darvocet lawyers continue to file new cases in federal
courts across the country, they will be transferred to the Eastern District of
Kentucky for coordinated handling before U.S District Judge Danny C. Reeves. The deaths from
Darvocet and Darvon are often caused because the drug is converted into a
metabolite that is toxic to the heart and lasts longer in the body, potentially
causing cardiac depression. It has also been associated with suicides,
intentional and unintentional overdoses.
Just the FDA doing it's work.
ReplyDeletebaby with cerebral palsy
Nice blog...
ReplyDeleteVisit my site:
AOL Search
AOL Mail Tech Support
AOL mail Help phone number